Advancing gastrointestinal cancer diagnostics: a systematic review and meta-analysis of circulating microRNA-1246 as a non-invasive biomarker

References

• Aalami A, Abdeahad H, Mokhtari A, Aalami F, Amirabadi A, Aliabadi EK, Pirzade O, Sahebkar A. 2024. Blood-based microRNAs as potential diagnostic biomarkers for melanoma: a meta-analysis. Curr Med Chem. 31:1–14. doi: 10.2174/0929867330666230509110111
   Google Scholar
• Aalami AH, Aalami F, Aliabadi EK, Amirabadi A, Sahebkar A. 2024. Detection of circulating cell-free DNA to diagnose hepatocellular carcinoma in Chinese population: a systematic review and meta-analysis. Curr Med Chem. 31(22):3345–3359. doi: 10.2174/0929867330666230622114235
   Google Scholar
• Aalami AH, Aalami F, Sahebkar A. 2023. Gastric cancer and circulating microRNAs: an updated systematic review and diagnostic meta-analysis. Curr Med Chem. 30(33):3798–3814. doi: 10.2174/0929867330666221121155905
   PubMed Web of Science ®Google Scholar
• Aalami AH, Abdeahad H, Aalami F, Amirabadi A. 2023. Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer. Urol Oncol. 41(1):52.e1–52.e10. doi: 10.1016/j.urolonc.2022.09.022
   PubMed Web of Science ®Google Scholar
• Aalami AH, Abdeahad H, Mesgari M, Sahebkar A. 2021. MicroRNA-223 in gastrointestinal cancers: a systematic review and diagnostic meta-analysis. Eur J Clin Invest. 51(2):e13448. doi: 10.1111/eci.13448
   PubMed Web of Science ®Google Scholar
• Aalami AH, Abdeahad H, Shoghi A, Mesgari M, Amirabadi A, Sahebkar A. 2022. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis. Expert Rev Mol Diagn. 22(2):201–211. doi: 10.1080/14737159.2022.2019016
   PubMed Web of Science ®Google Scholar
• Aalami AH, Hoseinzadeh M, Hosseini Manesh P, Jiryai Sharahi A, Kargar Aliabadi E. 2022. Carcinogenic effects of heavy metals by inducing dysregulation of microRNAs: a review. Mol Biol Rep. 49(12):12227–12238. doi: 10.1007/s11033-022-07897-x
   PubMed Web of Science ®Google Scholar
• Aalami AH, Shahriari A, Mazaheri M, Aalami F, Amirabadi A, Sahebkar A. 2023. Diagnostic accuracy of Tumor M2-Pyruvate Kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: a systematic review and meta-analysis. Clin Biochem. 120:110652. doi: 10.1016/j.clinbiochem.2023.110652
   PubMed Web of Science ®Google Scholar
• Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. 2020. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 159(1):335–349.e15. doi: 10.1053/j.gastro.2020.02.068
   PubMed Web of Science ®Google Scholar
• Bahrami A, Jafari A, Ferns GA. 2022. The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor? Biomed Pharmacother. 145:112394. doi: 10.1016/j.biopha.2021.112394
   PubMed Web of Science ®Google Scholar
• Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell. 136(2):215–233. doi: 10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S. 2018. microRNA-1246 is an exosomal biomarker for aggressive prostate cancer. Cancer Res. 78(7):1833–1844. doi: 10.1158/0008-5472.CAN-17-2069
   PubMed Web of Science ®Google Scholar
• Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, Yuan YF, Cheung TT, Cheung ST, Wang XQ, et al. 2016. Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology. 64(6):2062–2076. doi: 10.1002/hep.28821
   PubMed Web of Science ®Google Scholar
• Chen S, Fu Z, Wen S, Yang X, Yu C, Zhou W, Lin Y, Lv Y. 2021. Expression and diagnostic value of miR-497 and miR-1246 in hepatocellular carcinoma. Front Genet. 12:666306. doi: 10.3389/fgene.2021.666306
   PubMed Web of Science ®Google Scholar
• Chuma M, Toyoda H, Matsuzaki J, Saito Y, Kumada T, Tada T, Kaneoka Y, Maeda A, Yokoo H, Ogawa K, et al. 2019. Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma. Hepatol Res. 49(7):810–822. doi: 10.1111/hepr.13338
   PubMed Web of Science ®Google Scholar
• Fathullahzadeh S, Mirzaei H, Honardoost MA, Sahebkar A, Salehi M. 2016. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia. Cancer Gene Ther. 23(10):327–332. doi: 10.1038/cgt.2016.34
   PubMed Web of Science ®Google Scholar
• Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. 2018. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Ferracin M, Veronese A, Negrini M. 2010. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 10(3):297–308. doi: 10.1586/erm.10.11
   PubMed Web of Science ®Google Scholar
• Furuya-Kanamori L, Kostoulas P, Doi SAR. 2021. A new method for synthesizing test accuracy data outperformed the bivariate method. J Clin Epidemiol. 132:51–58. doi: 10.1016/j.jclinepi.2020.12.015
   PubMed Web of Science ®Google Scholar
• Gheorghe G, Diaconu CC, Ionescu V, Constantinescu G, Bacalbasa N, Bungau S, Gaman M-A, Stan-Ilie M. 2022. Risk factors for pancreatic cancer: emerging role of viral hepatitis. J Pers Med. 12(1):83. doi: 10.3390/jpm12010083
   PubMed Web of Science ®Google Scholar
• Grande AJ, Silva V, Riera R, Medeiros A, Vitoriano SG, Peccin MS, Maddocks M. 2014. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev. 3:CD010804. doi: 10.1002/14651858.CD010804.pub2
   Google Scholar
• Guo S, Zhang J, Wang B, Zhang B, Wang X, Huang L, Liu H, Jia B. 2018. A 5-serum miRNA panel for the early detection of colorectal cancer. Onco Targets Ther. 11:2603–2614. doi: 10.2147/OTT.S153535
   PubMed Web of Science ®Google Scholar
• Hasegawa S, Eguchi H, Nagano H, Konno M, Tomimaru Y, Wada H, Hama N, Kawamoto K, Kobayashi S, Nishida N, et al. 2014. MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer. Br J Cancer. 111(8):1572–1580. doi: 10.1038/bjc.2014.454
   PubMed Web of Science ®Google Scholar
• Hoshino I, Ishige F, Iwatate Y, Gunji H, Kuwayama N, Nabeya Y, Yokota H, Takeshita N, Iida K, Nagase H, et al. 2021. Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma. Plos One. 16(3):e0248016. doi: 10.1371/journal.pone.0248016
   PubMed Web of Science ®Google Scholar
• Hoshino I, Ishige F, Iwatate Y, Gunji H, Shiratori F, Kuwayama N, Nabeya Y, Takeshita N, Matsubara H. 2020. Usefulness of serum miR‑1246/miR‑106b ratio in patients with esophageal squamous cell carcinoma. Oncol Lett. 20(6):350–351. doi: 10.3892/ol.2020.12213
   PubMed Web of Science ®Google Scholar
• Huang JL, Fu YP, Gan W, Liu G, Zhou PY, Zhou C, Sun BY, Guan RY, Zhou J, Fan J, et al. 2020. Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Cancer Lett. 476:140–151. doi: 10.1016/j.canlet.2020.02.012
   PubMed Web of Science ®Google Scholar
• Huang J, Lucero-Prisno DE, III, Zhang L, Xu W, Wong SH, Ng SC, Wong MC. 2023. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol. 20(5):271–287. doi: 10.1038/s41575-022-00726-3
   PubMed Web of Science ®Google Scholar
• Ishige F, Hoshino I, Iwatate Y, Chiba S, Arimitsu H, Yanagibashi H, Nagase H, Takayama W. 2020. MIR1246 in body fluids as a biomarker for pancreatic cancer. Sci Rep. 10(1):8723. doi: 10.1038/s41598-020-65695-6
   PubMed Web of Science ®Google Scholar
• Islam M, Alam MK, Paul BK, Koundal D, Zaguia A, Ahmed K. 2022. Identification of molecular biomarkers and key pathways for Esophageal Carcinoma (EsC): a bioinformatics approach. Biomed Res Int. 2022:5908402–5908414. doi: 10.1155/2022/5908402
   PubMed Web of Science ®Google Scholar
• Jelski W, Orywal K, Laniewska M, Szmitkowski M. 2010. The diagnostic value of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) measurement in the sera of gastric cancer patients. Clin Exp Med. 10(4):215–219. doi: 10.1007/s10238-010-0097-2
   PubMed Web of Science ®Google Scholar
• Konno M, Koseki J, Asai A, Yamagata A, Shimamura T, Motooka D, Okuzaki D, Kawamoto K, Mizushima T, Eguchi H, et al. 2019. Distinct methylation levels of mature microRNAs in gastrointestinal cancers. Nat Commun. 10(1):3888. doi: 10.1038/s41467-019-11826-1
   PubMed Web of Science ®Google Scholar
• Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA. 2022. Contributing factors common to COVID‑19 and gastrointestinal cancer. Oncol Rep. 47(1):1–16. doi: 10.3892/or.2021.8227
   PubMed Web of Science ®Google Scholar
• Li J, Tao Y, Cong H, Zhu E, Cai T. 2022. Predicting liver cancers using skewed epidemiological data. Artif Intell Med. 124:102234. doi: 10.1016/j.artmed.2021.102234
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan C, Yin S, Wang T, Zhu M, Liu L, Jin G. 2023. Genetic risk, metabolic syndrome, and gastrointestinal cancer risk: a prospective cohort study. Cancer Med. 12(1):597–605. doi: 10.1002/cam4.4923
   PubMed Web of Science ®Google Scholar
• Machida T, Tomofuji T, Maruyama T, Yoneda T, Ekuni D, Azuma T, Miyai H, Mizuno H, Kato H, Tsutsumi K, et al. 2016. miR‑1246 and miR‑4644 in salivary exosome as potential biomarkers for pancreatobiliary tract cancer. Oncol Rep. 36(4):2375–2381. doi: 10.3892/or.2016.5021
   PubMed Web of Science ®Google Scholar
• Mei J, Xu R, Hao L, Zhang Y. 2020. MicroRNA-613: a novel tumor suppressor in human cancers. Biomed Pharmacother. 123:109799. doi: 10.1016/j.biopha.2019.109799
   PubMed Web of Science ®Google Scholar
• Mirzaei HR, Sahebkar A, Mohammadi M, Yari R, Salehi H, Jafari MH, Namdar A, Khabazian E, Jaafari MR, Mirzaei H. 2016. Circulating micrornas in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers. Curr Pharm Des. 22(34):5257–5269. doi: 10.2174/1381612822666160303110838
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 4(1):1. doi: 10.1186/2046-4053-4-1
   PubMed Web of Science ®Google Scholar
• Moses LE, Shapiro D, Littenberg B. 1993. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 12(14):1293–1316. doi: 10.1002/sim.4780121403
   PubMed Web of Science ®Google Scholar
• Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, et al. 2018. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 9(20):15350–15364. doi: 10.18632/oncotarget.24601
   PubMedGoogle Scholar
• Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, et al. 2014. Circulating exosomal microRNAs as biomarkers of colon cancer. PloS One. 9(4):e92921. doi: 10.1371/journal.pone.0092921
   PubMed Web of Science ®Google Scholar
• Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. 2022. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 7(3):262–274. doi: 10.1016/S2468-1253(21)00426-X.
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, Gohari-Ensaf F. 2020. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 42:e2020004. doi: 10.4178/epih.e2020004
   PubMed Web of Science ®Google Scholar
• Qasemi Rad M, Pouresmaeil V, Hosseini Mojahed F, Amirabadi A, Aalami AH. 2022. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer. Mol Biol Rep. 49(7):6975–6985. doi: 10.1007/s11033-022-07465-3
   PubMed Web of Science ®Google Scholar
• Salah M, Shaheen I, El-Shanawany P, Saad NE, Saad R, El Guibaly M, Momen N. 2020. Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital. Afr Health Sci. 20(3):1283–1291. doi: 10.4314/ahs.v20i3.33
   PubMed Web of Science ®Google Scholar
• Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM, Ebrahimnejad H, Nahand JS, Hadjati J, Asrami MO, et al. 2016. Epi-drugs and epi-mirs: moving beyond current cancer therapies. Curr Cancer Drug Targets. 16(9):773–788. doi: 10.2174/1568009616666151207110143
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang J, Yang X, Liu Z. 2020. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Int J Clin Oncol. 25(1):89–99. doi: 10.1007/s10147-019-01532-9
   PubMed Web of Science ®Google Scholar
• Song M, Giovannucci E. 2016. Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States. JAMA Oncol. 2(9):1154–1161. doi: 10.1001/jamaoncol.2016.0843
   PubMed Web of Science ®Google Scholar
• Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, et al. 2013. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 108(3):644–652. doi: 10.1038/bjc.2013.8
   PubMed Web of Science ®Google Scholar
• Vahid F, Davoodi SH. 2021. Nutritional factors involved in the etiology of gastric cancer: a systematic review. Nutr Cancer. 73(3):376–390. doi: 10.1080/01635581.2020.1756353
   PubMed Web of Science ®Google Scholar
• Wang S, Zeng Y, Zhou JM, Nie SL, Peng Q, Gong J, Huo JR. 2016. MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction. Mol Med Rep. 13(1):273–280. doi: 10.3892/mmr.2015.4557
   PubMed Web of Science ®Google Scholar
• Watson J, Mounce L, Bailey SE, Cooper SL, Hamilton W. 2019. Blood markers for cancer. BMJ. 367:l5774. doi: 10.1136/bmj.l5774
   PubMed Web of Science ®Google Scholar
• Wei J, Yang L, Wu YN, Xu J. 2020. Serum miR-1290 and miR-1246 as potential diagnostic biomarkers of human pancreatic cancer. J Cancer. 11(6):1325–1333. doi: 10.7150/jca.38048
   PubMed Web of Science ®Google Scholar
• Xie C, Huang T, Teng Z, Xu S, Bu J, Li M, Zhang Y, Zhang J. 2019. A meta-analysis of the diagnostic value of microRNA-1246 for malignant tumors. Medicine (Baltimore). 98(22):e15848. doi: 10.1097/MD.0000000000015848
   PubMed Web of Science ®Google Scholar
• Yamada N, Tsujimura N, Kumazaki M, Shinohara H, Taniguchi K, Nakagawa Y, Naoe T, Akao Y. 2014. Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim Biophys Acta. 1839(11):1256–1272. doi: 10.1016/j.bbagrm.2014.09.002
   PubMed Web of Science ®Google Scholar
• Zou X, Zhu D, Zhang H, Zhang S, Zhou X, He X, Zhu J, Zhu W. 2020. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis. Gene. 727:144243. doi: 10.1016/j.gene.2019.144243
   PubMed Web of Science ®Google Scholar